These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6766085)

  • 1. Leukemia-induced alterations of serum glycosyltransferase enzymes.
    Kuhns WJ; Oliver RT; Watkins WM; Greenwell P
    Cancer Res; 1980 Feb; 40(2):268-75. PubMed ID: 6766085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of altered alpha-2-L-fucosyltransferase levels in serum of leukemic patients.
    Skacel PO; Watkins WM
    Cancer Res; 1988 Jul; 48(14):3998-4001. PubMed ID: 3164255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrofocusing patterns of fucosyltransferases in plasma of patients with neoplastic disease.
    Kessel D; Ratanatharathorn V; Chou TH
    Cancer Res; 1979 Sep; 39(9):3377-80. PubMed ID: 89896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of blood group A and H antigens on red cells from an acute leukemic patient.
    Matsuki T; Shimano S; Furukawa K
    Exp Clin Immunogenet; 1992; 9(3):125-9. PubMed ID: 1303092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Properties of alpha-N-acetylgalactosaminyltransferases in sera of group A and weak A subjects].
    Cartron JP
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):67-88. PubMed ID: 823628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy.
    Khilanani P; Chou TH; Kessel D
    Cancer Res; 1978 Jan; 38(1):181-4. PubMed ID: 271043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
    Lin M; Meng X
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood-group A- and H-specified glycosyltransferase levels in the sera of newborn infants and their mothers.
    Tilley CA; Crookston MC; Crookston JH; Shindman J; Schachter H
    Vox Sang; 1978; 34(1):8-13. PubMed ID: 414451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte enzyme abnormalities in leukemias.
    Sharma S; Pati HP
    J Assoc Physicians India; 2006 Jun; 54():453-7. PubMed ID: 16909693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of telomerase activity levels in acute leukemia.
    Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
    Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
    Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
    J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
    Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
    Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum thymidine kinase in children with acute leukemia.
    Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
    Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on gene expression of TGF beta 1 and its receptor in leukemia cells and the serum TGF beta 1 level in the patients with acute leukemia].
    Chen Y; Lu L; Wang L
    Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):576-80. PubMed ID: 11263341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.